Trial Details

TERMINATED
Basic Information
Clinical ID c1253
Identifier NCT05644665
Trial Title A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Ozanimod|DRUG: Placebo
Participant Information
Sponsor Bristol-Myers Squibb
City Hefei
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2022-12-09
Primary Completion Date 2025-03-07
Completion Date 2025-03-07